REVIEW
|
doi:10.20944/preprints202306.0956.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
NSCLC,; Immunotherapy; Immune Checkpoint Inhibitors; Special populations
Online: 13 June 2023 (16:01:04 CEST)